The negative prognostic impact of MYC rearrangements (MYC-R) as well as MYC- and concomitant BCL2- or BCL6 rearrangements (double-hit lymphoma; DHL) has been shown in several DLBCL cohorts [6, 7]. This evidence concerns the gene MYC and diffuse large B-cell lymphoma.